Interestingly, GILT expression in melanoma lines resulted in elevated CD86 protein levels detected by western blot analysis (Supplementary Figure S2B), consistent with the immunofluorescence analysis of the J3.DR4.GILT tumor (Figure 1C). This evidence concerns the gene CD86 and melanoma.